Sponsored by Spryng with OsteoCushion Technology

With an innovative non-surgical, non-drug veterinary medical device, horses may enjoy a better quality of life and remain active longer.

Lameness issues, joint pain and osteoarthritis. They’re painful. They’re frustrating. And they’re extremely common. In fact, the chronic, progressive degeneration of the cartilage is believed to be responsible for up to 60% of all equine lameness.1 The related economic impact is substantial, with annual costs estimated as high as $1 billion per year in the United States alone.2

Limitations of Current Treatments

Despite vast, ongoing research efforts, a cure for lameness issues continues to elude researchers. Veterinarians don’t have a universal solution to turn to and lean on pain and inflammation symptom management through combinations of conventional therapies such as non-steroidal anti-inflammatory drugs (NSAIDs), intra-articular corticosteroids and nutraceuticals. Along with inconsistent results and the inability to stop disease progression, each of these therapies carries with it unique drawbacks.

Introducing Spryng with OsteoCushion Technology: An Innovative First Line of Defense

Spryng with OsteoCushion Technology is an innovative injectable veterinary device that takes the management of lameness issues into a new arena by addressing the root cause of the conditions — missing and damaged cartilage. Each Spryng intra-articular injection supplies a shock absorbing matrix with natural fluid biomechanics that work together with synovial fluid to mimic joint cartilage in both form and function. When a horse jumps, runs or performs any movement with joint impact, the Spryng matrix’s spongy, cushioning action absorbs and releases synovial fluid in response. Spryng also provides a natural scaffold, potentially protecting the joint from further injury, unlike other lameness management options that may only mask pain or treat symptoms.

An Effective Injectable Device Solution

While the effects of a Spryng with OsteoCushion Technology injection are rapid — with most horses returning to normal daily activities, high impact sports, competitive events and training — they provide long duration of protection. Upon injection into the affected joint, the naturally-derived, inert, precisely-sized matrix particles readily integrate with joint fluid and conform to synovial space. These micro-particles do not readily dissolve, are resistant to interstitial proteases, and are too large to pass through the pores of the synovium, thus providing long-duration joint protection after a single application. In fact, unlike conventional treatments that require repeated injections or ongoing administration, one Spryng injection may provide relief for more than 12 months, making it an effective and economical solution for managing osteoarthritis, lameness issues and joint-related conditions.

Joint protection with Spryng

Addressing Lameness Issues, Not Masking Symptoms

After a Spryng with OsteoCushion Technology injection, in many cases, study animals no longer needed NSAIDS for pain relief — with most horses returning to normal daily activities, high impact sports, competitive events and training. This contributes to reducing inflammation, greater joint health and a slowing of the progression of lameness issues, joint degeneration and osteoarthritis. There may be no cure for lameness issues, but management with Spryng could be the key to getting an animal back up and running.

Ask your equine veterinarian if Spryng with OsteoCushion Technology could be the right tool to aid in the management of your horse’s lameness or joint issues.

To learn more, visit SpryngHealth.com

1. Orth MW, Schlueter AE. Equine osteoarthritis: a brief review of the disease and its causes. Equine Comp Exerc Physiol (2004) 1:221–31. doi: 10.1079/ecp200428 2. Keegan KG. Evidence-based lameness detection and quantification. Vet Clin North Am Equine Pract (2007) 23:403–23. doi:10.1016/j.cveq.2007.04.008


Email comments or questions to [email protected]

Write A Comment